Related Experiment Video
Updated: Jul 5, 2025

A High-content In Vitro Pancreatic Islet β-cell Replication Discovery Platform
Published on: July 16, 2016
circGlis3 promotes β-cell dysfunction by binding to heterogeneous nuclear ribonucleoprotein F and encoding
Li Xiong1,2, Yingying Gong3, Huashan Liu1,2
1Department of Colorectal Surgery, The Sixth Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong, China.
Abstract:
Circular RNAs (circRNAs) are crucial regulators of β-cell function and are involved in lipotoxicity-induced β-cell damage in type 2 diabetes mellitus (T2DM). We previously identified that circGlis3, a circRNA derived from exon 4 of the diabetes susceptibility gene Glis3, was upregulated in lipotoxic β cells. However, the functional role and molecular mechanism of circGlis3 in β cells remain largely unknown. Here, we revealed that the splicing factor CUGBP Elav-Like Family Member 1 (CELF1) facilitated the biogenesis of circGlis3. Moreover, we established a transgenic mouse model and confirmed that the overexpression of circGlis3 impaired β-cell function. Mechanistically, circGlis3 bound to heterogeneous nuclear ribonucleoprotein F (hnRNPF) and blocked its nuclear translocation, thereby reducing Sirt1 levels. Additionally, circGlis3 encoded a 348aa protein that interacted with GLIS3 and inhibited its transcriptional activity. Our data uncover a critical role of circGlis3 in β-cell dysfunction, suggesting that circGlis3 may be a potential therapeutic target for T2DM.
Insights
Circular RNAs (circRNAs) regulate β-cell function and are implicated in type 2 diabetes mellitus (T2DM). This study reveals circGlis3 impairs β-cell function by affecting protein interactions and gene expression, suggesting it as a T2DM therapeutic target.
Area of Science:
- Endocrinology
- Molecular Biology
- Genetics
Background:
- Circular RNAs (circRNAs) are key regulators of pancreatic β-cell function.
- Lipotoxicity-induced β-cell damage in type 2 diabetes mellitus (T2DM) involves circRNAs.
- circGlis3, a circRNA from the Glis3 gene, is upregulated in lipotoxic β-cells, but its function is unknown.
Purpose of the Study:
- To elucidate the functional role and molecular mechanism of circGlis3 in β-cell function.
- To investigate the involvement of circGlis3 in T2DM pathogenesis.
Main Methods:
- Investigated the biogenesis of circGlis3, facilitated by the splicing factor CUGBP Elav-Like Family Member 1 (CELF1).
- Generated and analyzed a transgenic mouse model overexpressing circGlis3.
- Examined the molecular interactions of circGlis3 with heterogeneous nuclear ribonucleoprotein F (hnRNPF) and GLIS3.
Main Results:
- Overexpression of circGlis3 in a mouse model impaired β-cell function.
- circGlis3 binds to hnRNPF, inhibiting its nuclear translocation and reducing Sirt1 levels.
- circGlis3 encodes a protein that interacts with GLIS3, suppressing its transcriptional activity.
Conclusions:
- circGlis3 plays a critical role in β-cell dysfunction.
- circGlis3 may represent a potential therapeutic target for T2DM.
Related Concept Videos
Insulin Secretory Vesicles
Cell Specific Gene Expression
Protein Folding Quality Check in the RER
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion
Insulin and C-peptide are...
Insulin: The Receptor and Signaling Pathways
Hormones Regulating Blood Glucose
In addition to accelerating glucose uptake and utilization, insulin has...

